Cargando…

Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy

BACKGROUND: In real-world clinical practice, biologics in inflammatory bowel diseases (IBD) may be discontinued for a variety of reasons, including discontinuation initiated by gastroenterologists. The aims of the study are to report outcomes after discontinuation and predictors of prognosis after a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shivaji, Uday N., Bazarova, Alina, Critchlow, Tamsin, Smith, Samuel C. L., Nardone, Olga Maria, Love, Melanie, Davis, Joanne, Ghosh, Subrata, Iacucci, Marietta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162203/ https://www.ncbi.nlm.nih.gov/pubmed/34104206 http://dx.doi.org/10.1177/1756284820981216

Ejemplares similares

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

Emotional state should not be used to differentiate IBD from IBS – Authors' reply
por: Iacucci, Marietta, et al.
Publicado: (2020)

Tests that now deserve to be more widely adopted in IBD clinical practice
por: Labarile, Nunzia, et al.
Publicado: (2020)

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives
por: Majumder, Snehali, et al.
Publicado: (2022)

New endoscopic tools in inflammatory bowel disease
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
por: Smith, Samuel C. L., et al.
Publicado: (2021)

Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
por: Nardone, Olga Maria, et al.
Publicado: (2019)

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study
por: Iacucci, Marietta, et al.
Publicado: (2022)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Diverse Immune Effects of Bovine Colostrum and Benefits in Human Health and Disease
por: Ghosh, Subrata, et al.
Publicado: (2021)

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
por: Shivaji, Uday N., et al.
Publicado: (2019)

A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis
por: Iacucci, Marietta, et al.
Publicado: (2022)

Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Training methods in optical diagnosis and characterization of colorectal polyps: a systematic review and meta-analysis
por: Smith, Samuel C.L., et al.
Publicado: (2021)

Blockade of IL-23: What is in the Pipeline?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

High definition i-SCAN endoscopy with water immersion technique accurately reflects histological severity of celiac disease
por: Iacucci, Marietta, et al.
Publicado: (2016)

PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis
por: Nardone, Olga Maria, et al.
Publicado: (2022)

High-definition-iSCAN virtual chromoendoscopy has high sensitivity and specificity for the diagnosis of eosinophilic esophagitis
por: Gregory, Eustace, et al.
Publicado: (2017)

Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease
por: Lee, Lik Hang, et al.
Publicado: (2017)

PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system
por: Gui, Xianyong, et al.
Publicado: (2022)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
por: Iacucci, Marietta, et al.
Publicado: (2020)

Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort
por: Kaplan, Jess L., et al.
Publicado: (2023)

Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women
por: Balasubramanian, Akhila, et al.
Publicado: (2013)

Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
por: Proietti, E, et al.
Publicado: (2021)

Next-Generation Endoscopy in Inflammatory Bowel Disease
por: Zammarchi, Irene, et al.
Publicado: (2023)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Prevalence, predictors and economic consequences of no-shows
por: Kheirkhah, Parviz, et al.
Publicado: (2016)

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
por: Dai, Cong, et al.
Publicado: (2014)

Consequences of the discontinuous replacement of radiated energy on the performance of LEP 200
por: Ruggiero, F
Publicado: (1990)

Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges
por: Su, Song, et al.
Publicado: (2020)

CARRoT: R-package for predictive modelling by means of regression, adjusted for multiple regularisation methods
por: Bazarova, Alina, et al.
Publicado: (2023)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom
por: Siau, Keith, et al.
Publicado: (2020)

Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]
por: Louis, Edouard, et al.
Publicado: (2022)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Discontinuation of carbamazepine due to concerns of long‐term consequences of enzyme induction
por: Mäkinen, Jussi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i8rr74amrb77a269rv34coa1kq